IMMUNE CHECKPOINT INHIBITOR
Clinical trials for IMMUNE CHECKPOINT INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITOR trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in slowing advanced prostate cancer
Disease control CompletedThis study tested whether adding the experimental drug lorigerlimab to standard chemotherapy (docetaxel) can delay cancer growth in men with a type of advanced prostate cancer that no longer responds to hormone therapy. About 150 participants received either the combination or ch…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 26, 2026 03:07 UTC
-
Heart alert: blood test may catch immunotherapy side effects early
Knowledge-focused CompletedThis study reviewed medical records of 300 cancer patients treated with immune checkpoint inhibitors to see if measuring troponin (a heart enzyme) could predict serious heart events like heart attacks or myocarditis. The goal was to find out if this monitoring helps prevent heart…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Sponsor: Institut Mutualiste Montsouris • Aim: Knowledge-focused
Last updated May 20, 2026 11:53 UTC